Effect of trapidil on prostacyclin generation of arterial wall. 1980

T Kawamura, and T Kitani, and Y Okajima, and S Okuda, and S Urano, and M Watada, and M Nakagawa, and H Ijichi

Prostacyclin (PGI2) has been reported to be a labile but potent inhibitor of platelet aggregation and a powerful vasodilator. This paper reports the effect of trapidil on PGI2 generation in rat aorta by means of bioassay system. The aortic ring was incubated in 0.05 M Tris HCl buffer (pH 7.5) for 10 min. This incubation medium was added into human PRP, and then incubated at 37 degrees C for 2 min., and ADP was added. PGI2 activity was assayed by the inhibitory percentage of ADP induced platelet aggregation. When the aortic ring was incubated in a medium containing trapidil, PGI2 generation was accelerated. This acceleration was inhibited by pretreatment with indomethacin. Moreover, the aortas of rats intravenously injected with 30 mg/kg of trapidil were incubated in the same way, and PGI2 activity in the medium was estimated. More potent PGI2 activity was observed in the aortas of rat treated with trapidil compared with the controls. These results indicate that acceleration of PGI2 generation from aorta by trapidil is involved in the mode of action of this drug of thrombus formation.

UI MeSH Term Description Entries
D008297 Male Males
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001013 Aorta, Thoracic The portion of the descending aorta proceeding from the arch of the aorta and extending to the DIAPHRAGM, eventually connecting to the ABDOMINAL AORTA. Aorta, Ascending,Aorta, Descending,Aortic Arch,Aortic Root,Arch of the Aorta,Descending Aorta,Sinotubular Junction,Ascending Aorta,Thoracic Aorta,Aortic Roots,Arch, Aortic,Ascending Aortas,Junction, Sinotubular,Root, Aortic,Sinotubular Junctions
D001158 Arteries The vessels carrying blood away from the heart. Artery
D014192 Trapidil A coronary vasodilator agent. Trapymin,Rocornal

Related Publications

T Kawamura, and T Kitani, and Y Okajima, and S Okuda, and S Urano, and M Watada, and M Nakagawa, and H Ijichi
August 1982, Biulleten' eksperimental'noi biologii i meditsiny,
T Kawamura, and T Kitani, and Y Okajima, and S Okuda, and S Urano, and M Watada, and M Nakagawa, and H Ijichi
January 1982, Arteriosclerosis (Dallas, Tex.),
T Kawamura, and T Kitani, and Y Okajima, and S Okuda, and S Urano, and M Watada, and M Nakagawa, and H Ijichi
May 1981, Japanese heart journal,
T Kawamura, and T Kitani, and Y Okajima, and S Okuda, and S Urano, and M Watada, and M Nakagawa, and H Ijichi
November 1989, Archives des maladies du coeur et des vaisseaux,
T Kawamura, and T Kitani, and Y Okajima, and S Okuda, and S Urano, and M Watada, and M Nakagawa, and H Ijichi
September 1982, Biulleten' eksperimental'noi biologii i meditsiny,
T Kawamura, and T Kitani, and Y Okajima, and S Okuda, and S Urano, and M Watada, and M Nakagawa, and H Ijichi
January 1983, Biomedica biochimica acta,
T Kawamura, and T Kitani, and Y Okajima, and S Okuda, and S Urano, and M Watada, and M Nakagawa, and H Ijichi
December 1990, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
T Kawamura, and T Kitani, and Y Okajima, and S Okuda, and S Urano, and M Watada, and M Nakagawa, and H Ijichi
July 1974, The Johns Hopkins medical journal,
T Kawamura, and T Kitani, and Y Okajima, and S Okuda, and S Urano, and M Watada, and M Nakagawa, and H Ijichi
May 1977, Archives internationales de pharmacodynamie et de therapie,
T Kawamura, and T Kitani, and Y Okajima, and S Okuda, and S Urano, and M Watada, and M Nakagawa, and H Ijichi
October 1983, Journal of the American College of Cardiology,
Copied contents to your clipboard!